Literature DB >> 19601881

CD44 and its role in inflammation and inflammatory diseases.

Pauline Johnson1, Brian Ruffell.   

Abstract

The cell adhesion molecule CD44 is expressed on the majority of immune cells and is responsible for mediating adhesion to the extracellular matrix glycosaminoglycan, hyaluronan. The binding of CD44 to hyaluronan is induced on T lymphocytes after activation by antigen and on monocytes after stimulation by inflammatory agents. Under inflammatory conditions, CD44 on endothelial cells presents hyaluronan to CD44 on activated T lymphocytes and mediates a rolling interaction under flow conditions. This rolling interaction together with chemokine signaling upregulates integrin-mediated adhesion, which induces cell arrest and leads to subsequent migration to the inflammatory site. Studies with monoclonal antibodies against CD44 in mouse models of chronic inflammatory disease showed reduced disease severity attributed to reduced leukocyte recruitment. More recent investigations, taking advantage of the availability of CD44 null mice, further established a role for CD44 in leukocyte recruitment to inflammatory sites. These studies also revealed a role for CD44 in limiting the inflammatory response and resolving inflammation in models of lung injury and hepatitis. Here we describe the contributions of CD44 and hyaluronan to an inflammatory response and discuss the role of CD44 in both promoting and resolving inflammation in various mouse models of inflammatory disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19601881     DOI: 10.2174/187152809788680994

Source DB:  PubMed          Journal:  Inflamm Allergy Drug Targets        ISSN: 1871-5281


  82 in total

Review 1.  Factors influencing the use and interpretation of animal models in the development of parenteral drug delivery systems.

Authors:  Marilyn N Martinez
Journal:  AAPS J       Date:  2011-10-05       Impact factor: 4.009

2.  CD44 receptor unfolding enhances binding by freeing basic amino acids to contact carbohydrate ligand.

Authors:  Amanda J Favreau; Christina E Faller; Olgun Guvench
Journal:  Biophys J       Date:  2013-09-03       Impact factor: 4.033

Review 3.  The CD44-HA axis and inflammation in atherosclerosis: A temporal perspective.

Authors:  Mia Krolikoski; James Monslow; Ellen Puré
Journal:  Matrix Biol       Date:  2018-05-21       Impact factor: 11.583

4.  Absence of specific alternatively spliced exon of CD44 in macrophages prevents colitis.

Authors:  B M Wittig; R Sabat; P Holzlöhner; E Witte-Händel; K Heilmann; K Witte; J Triebus; A Tzankov; J D Laman; B Bokemeyer; L Terracciano; C Schwärzler; H Kohler; R Volkmer; C Loddenkemper; K Wolk; U Hoffmann; U Günthert
Journal:  Mucosal Immunol       Date:  2017-11-29       Impact factor: 7.313

5.  Regional differences in stem cell/progenitor cell populations from the mouse achilles tendon.

Authors:  Michael J Mienaltowski; Sheila M Adams; David E Birk
Journal:  Tissue Eng Part A       Date:  2012-09-14       Impact factor: 3.845

6.  Multifaceted regulation of T cells by CD44.

Authors:  Bas Jg Baaten; Cheng-Rui Li; Linda M Bradley
Journal:  Commun Integr Biol       Date:  2010-11-01

7.  Intermediate Molecular Mass Hyaluronan and CD44 Receptor Interactions Enhance Neutrophil Phagocytosis and IL-8 Production via p38- and ERK1/2-MAPK Signalling Pathways.

Authors:  Cheng-Hsun Lu; Chia-Huei Lin; Ko-Jen Li; Chieh-Yu Shen; Cheng-Han Wu; Yu-Min Kuo; Ting-Syuan Lin; Chia-Li Yu; Song-Chou Hsieh
Journal:  Inflammation       Date:  2017-10       Impact factor: 4.092

8.  Hyaluronan-CD44 Interactions in Cancer: Paradoxes and Possibilities.

Authors:  Bryan P Toole
Journal:  Clin Cancer Res       Date:  2009-12-15       Impact factor: 12.531

9.  The polygenic nature of inhibitors in hemophilia A: results from the Hemophilia Inhibitor Genetics Study (HIGS) Combined Cohort.

Authors:  Jan Astermark; Sharyne M Donfield; Edward D Gomperts; John Schwarz; Erika D Menius; Anna Pavlova; Johannes Oldenburg; Bailey Kessing; Donna M DiMichele; Amy D Shapiro; Cheryl A Winkler; Erik Berntorp
Journal:  Blood       Date:  2012-12-06       Impact factor: 22.113

10.  Corticosteroid administration reduces the concentration of hyaluronan in bronchoalveolar lavage in a murine model of eosinophilic airway inflammation.

Authors:  Glenda Ernst; Silvina Lompardía; Rosalía Cordo Russo; Virginia Gentilini; Stella Venturiello; Fernando Galíndez; Pedro Grynblat; Silvia E Hajos
Journal:  Inflamm Res       Date:  2012-07-28       Impact factor: 4.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.